Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in
toxicity. Chem Res Toxicol 2000;13:135–160.
Bolze S, Bromet N, Gay-Feutry C, Massiere F, Boulieu R, Hulot T. Development of an
in vitroscreening model for the biosynthesis of acyl glucuronide metabolites and the
assessment of their reactivity toward human serum albumin. Drug Metab Dispos
2002;30:404–413.
Butterfield DA.b-Amyloid-associated free radical oxidative stress and neurotoxicity:
implications for Alzheimer’s disease. Chem Res Toxicol 1997;10:495–506.
Castro-Oerez J, Plumb R, Liang L, Yang E. A high-throughput liquid chromatography/
tandem mass spectrometry method for screening glutathione conjugates using exact
mass neutral loss acquisition. Rapid Commun Mass Spectrom 2005;19:798–804.
Cohen SD, Pumford NR, Khairallah EA, Boekelheide K, Pohl LR, Amouzadeh HR,
Hinson JA. Selective protein covalent binding and target organ toxicity. Toxicol
Appl Pharmacol 1997;143:1–12.
Coles B. Effects of modifying structure on electrophilic reactions with biological
nucleophiles. Drug Metab Rev 1984–1985;15:1307–1334.
Comporti M. Three models of free radical-induced cell injury. Chem Biol Interact
1989;72:1–56.
Correia MA, Ortiz de Montellano, PR. Inhibition of cytochrome P450 enzymes.
In: Ortiz de Montellano PR, editor. Cytochrome P450: structure, mechanism, and
biochemistrythird. New York: Kluwer Academic/Plenum Publishers; 2005; p 247–322.
Day SH, Mao A, White R, Schulz-Utermoehl T, Miller R, Beconi MG. A
semiautomated method for measuring the potential for protein covalent binding in
drug discovery. J Pharmacol Toxicol Methods 2005;52:278–285.
Degli Esposti M. Measuring mitochondrial reactive oxygen species. Methods
2002;26:335–340.
Dieckhaus CM, Fernandez-Metzler CL, King R, Krolikowski PH, Baillie TA. Negative
ion tandom mass spectrometry for the detection of glutathione conjugates. Chem Res
Toxicol 2005;18:630–638.
Doss GA, Miller RR, Zhang Z, Teffera Y, Nargund RP, Palucki B, Park MK, Tang
YS, Evans DC, Baillie TA, Stearns RA. Metabolic activation of a 1,3-disubstituted
piperazine derivative: evidence for a novel ring contraction to an imidazole. Chem
Res Toxicol 2005;18:271–276.
Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug–protein adducts: an industry
perspective on minimizing the potential for drug bioactivation in drug discovery and
development. Chem Res Toxicol 2004;17:3–16.
Gan J, Hsueh MM, Qu Q, Harper TW, Humphreys WG. Dansyl glutathione as a
trapping agent for the quantitative estimation and identification of reactive
metabolites. Chem Res Toxicol 2005;18:896–903.
Ge XS, Shen J, Subramanyam B, Tseng JL, editors. The development of a strategy for
unambiguous identification of reactive intermediate/metabolite. 54th ASMS
Conference on Mass Spectrometry and Allied Topics; 2006 May 28–June 1;
Seattle. Washington: Poster # ThP 166;2006.
Gorrod JW, Sai Y. Recognition of novel artifacts produced during the microsomal
incubation of secondary alicyclic amines in the presence of cyanide. Xenobiotica
1997;27:389–399.
REFERENCES 473